Ligand Pharmaceuticals
LGND
#2962
Rank
A$7.93 B
Marketcap
A$398.08
Share price
-0.43%
Change (1 day)
54.62%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): A$0.28 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.27 Billion. In 2025 the company made an earning of A$0.22 Billion, an increase over its 2024 earnings that were of A$7.79 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) A$0.28 B25.57%
2025 A$0.22 B2848.57%
2024 A$7.79 M-91.37%
2023 A$90.31 M-7.59%
2022 A$97.73 M4%
2021 A$93.97 M296.42%
2020 A$23.7 M-97.97%
2019 A$1.16 B275.62%
2018 A$0.31 B237.48%
2017 A$92.2 M49.05%
2016 A$61.86 M55.41%
2015 A$39.8 M36.87%
2014 A$29.08 M29.59%
2013 A$22.44 M1309.35%
2012 A$1.59 M-43.97%
2011 A$2.84 M-113.19%
2010 -A$21.55 Million59.86%
2009 -A$13.48 Million-61.33%
2008 -A$34.86 Million-58.75%
2007 -A$84.5 Million20.52%
2006 -A$70.12 Million81.27%
2005 -A$38.68 Million
2003 -A$26.93 Million-20.6%
2002 -A$33.92 Million4.38%
2001 -A$32.49 Million-48.83%
2000 -A$63.49 Million-19.74%
1999 -A$79.11 Million-19.06%
1998 -A$97.74 Million126.71%
1997 -A$43.11 Million-5.83%
1996 -A$45.78 Million136.23%
1995 -A$19.38 Million-33.97%
1994 -A$29.35 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$36.47 B 13,538.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$14.87 B 5,460.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$43.70 B 16,240.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$12.75 B 4,670.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.72 Billion-366.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$18.46 B 6,804.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$13.47 B 4,938.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$14.05 B 5,155.99%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$86.9 Million-132.49%๐Ÿ‡บ๐Ÿ‡ธ USA